Company intelligence
Clario
About Clario
Clario, part of Thermo Fisher Scientific, is a leading provider of endpoint data solutions to the life sciences industry. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported more than 30,000 clinical trial opportunities in more than 100 countries. Our global team of science, technology, and operational experts have supported over 70% of all FDA drug approvals since 2015. For more information, visit thermofisher.com/clario
Verified activity
Signals from Clario
16 published signals
Presence & Recognition
Clario joined research leaders at the 2026 CNS Innovation Forum in Shanghai to explore new pathways for CNS drug development.
Reported by Clario
Research & Knowledge
Clario published a research paper titled Can AI-Enabled Intratumoral CT Imaging Threshold Segmentation Help Predict Visceral Pleural Invasion in Lung Cancer Patients?
Reported by Brett Hoover
Presence & Recognition
Clario will be attending DPHARM in Boston on Tuesday, September 15, sharing perspectives on integrated technology, analytics, and operational support for sponsors.
Reported by Andrew Adabie
People
Clario is hiring a Clinical Scientist, Neuroscience at Thermo Fisher Scientific to advance new therapies for Alzheimer's disease and dementia.
Reported by Matthew Stedman
Research & Knowledge
Clario announced the development of a new immuno-PET imaging tracer showing promise in lung cancer.
Reported by Brett Hoover
People
Clario is joining Thermo Fisher Scientific as a scientific leader to advance cardiovascular innovation across global clinical trials.
Reported by Matthew Stedman
Presence & Recognition
Clario is heading to Outsourcing in Clinical Trials Southern California this month in San Diego.
Reported by Clario
Research & Knowledge
Clario published a research paper titled Can Brain MRI Help Predict Spinal Cord Stimulation Response for Treating Urinary Incontinence in Stroke Survivors?
Reported by Brett Hoover
People
Clario hired Ágnes Schwarzenberger as a Senior Engineer, R&D Software Quality, based in Hungary, Budapest.
Reported by Ágnes Schwarzenberger
Research & Knowledge
Clario published an article exploring how thoughtful endpoint strategy supports more consistent decision-making across studies in early phase oncology.
Reported by Dejan Hušman
People
Clario is hiring a Procurement Buyer (f/m/d) in Estenfeld, Germany to support purchasing activities, coordinate with suppliers, and ensure goods and services are delivered efficiently to the business.
Reported by Nathalie Fischer
People
Clario hired an Accounts Receivable Associate in Hungary, Budapest, to manage billing, collections, account reconciliations, and customer account administration.
Reported by Ágnes Schwarzenberger
Presence & Recognition
Clario's scientific experts are featured in a webinar exploring how a more integrated approach supports efficacy, safety, and biomarker endpoint strategies in Alzheimer’s trials.
Reported by Clario
People
Clario is hiring as a scientific leader supporting global clinical trials
Reported by Matthew Stedman
Presence & Recognition
Clario is attending the DPHARM event in Boston on Tuesday, Sept 15, 2026, at Clario booth #515, featuring a session on New Frontiers in Digital Tech Solutions presented by John Ohrn, SVP, Global Partnerships.
Reported by Clario
Presence & Recognition
Clario hosted a free webinar discussing endpoint strategy in Alzheimer’s research, including imaging, cognitive, and functional measures.
Reported by Dejan Hušman